The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
Business continuity ensures that an organization can continue to operate in the event of a serious incident or disaster and encompasses strategic…
Webcast
in this short video webcast, Mike Schiller, Senior Director, AHRMM and Dennis Othman, Senior Director, SMI discuss the four key pillars of knowledg
On-Demand Educational Webinars
We all question whether some health care supply chains outperform others, which competencies separate those supply chain professionals from t
On-Demand Educational Webinars
This webinar takes a deep look at industries that have evolved successful and meaningful supplier relationships to advance shared value among a…